NY Pub Health L § 2500-C (2021)
2021 New York Laws PBH - Public Health Article 25 - Maternal and Child Health Title 1 - General Provisions 2500-C - Special Programs With Respect to Diethylstilbestrol.

§  2500-c. Special programs with respect to diethylstilbestrol. 1. For the purpose  of  identifying  persons  who  have  been  exposed  to  the potential  hazards  and  afflictions  of diethylstilbestrol, and for the purpose of educating the public concerning the symptoms  and  prevention of  associated  malignancies,  the commissioner shall establish, promote and maintain a public information campaign on  diethylstilbestrol.  Such campaign  shall  be conducted throughout the state and shall include but not be limited to a concerted effort at reaching those  persons  or  the offspring  of  persons  who  have  been exposed to diethylstilbestrol in order to encourage them to seek  medical  care  for  the  prevention  or treatment of any malignant condition.   2.  (a) The commissioner shall designate and enter into contracts with providers of health  care  for  the  purpose  of  establishing  regional screening   programs   for   diethylstilbestrol   exposed   persons.  In determining the provider with which to contract, the commissioner  shall consider  such  provider's  compliance with state and federally mandated standards, the location in relation to the geographical distribution  of persons exposed to diethylstilbestrol, and the capacity of such provider to  properly  screen for breast cancer, vaginal cancer, cervical cancer, vaginal  adenosis,  testicular  cancer  and  any  other  malignancy  and abnormal conditions resulting from DES exposure.  (b)  Each contract for a regional screening program shall be upon such terms and conditions as the commissioner determines, provided,  however, that  expenses  incurred shall be reimbursed by the state after applying against the total cost of screening and diagnosis the  amounts  received from  third  party payers and less any fee charged each person receiving such services where the commissioner shall determine a sliding fee scale based on ability to pay.   3. Each provider of  health  care  that  enters  into  a  contract  as provided  for  in  this  section  shall  conduct  a  training program in conjunction with the department for purposes of instructing  physicians, physician  assistants  and  nurses  within the respective health systems agency  in  the  detection,  diagnosis,  treatment  and  prevention   of diethylstilbestrol exposed persons.   4.  The  bureau  of  cancer control within the health department shall establish and maintain a registry of women who  took  diethylstilbestrol during   pregnancy   and   their   offspring   who   were   exposed   to diethylstilbestrol prenatally for the  purpose  of  follow-up  care  and treatment  of  long  term  problems  associated  with diethylstilbestrol exposure. Enrollment in the registry shall be upon a voluntary basis.   5. The commissioner may request and shall receive from any department, division, board, bureau, commission or agency of the  state  or  of  any political  subdivision  thereof  such assistance and data as will enable him to properly carry out his activities hereunder  and  effectuate  the purposes  herein  set  forth.  The  commissioner may also enter into any contract for services as he deems necessary with  a  private  agency  or concern upon said terms and conditions as he deems appropriate.   7. Special programs as provided for in this section shall be conducted within the appropriation made therefor.